Balyasny Asset Management L.P.

Position in MIRM — Mirum Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in MIRM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$49,795,683

+$27,214,812 QoQ

Shares Held

539,031

+88.6% QoQ

Ownership

0.884%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. MIRM ranks #10 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TERN	Terns Pharmaceuticals, Inc.	2,779,445	$146,532,340
2	ERAS	Erasca, Inc.	5,143,985	$83,229,677
3	TNGX	Tango Therapeutics, Inc.	3,826,659	$80,053,706
4	APLS	Apellis Pharmaceuticals, Inc.	1,917,501	$77,141,065
5	BMRN	Biomarin Pharmaceutical Inc	1,362,752	$76,981,860
6	CYTK	Cytokinetics Inc	992,545	$65,418,640
7	DAWN	Day One Biopharmaceuticals, Inc.	2,625,235	$56,285,038
8	FOLD	AMICUS THERAPEUTICS, INC.	3,827,513	$55,345,837

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$49,795,683	539,031	+88.6%	Shares	Sole	2026-05-15
2025-12-31	$22,580,871	285,870	-9.9%	Shares	Sole	2026-02-17
2025-09-30	$23,250,266	317,150	+1082.7%	Shares	Sole	2025-11-14
2025-03-31	$1,208,060	26,816	+43.1%	Shares	Sole	2025-05-15
2024-12-31	$774,609	18,733	+87.0%	Shares	Sole	2025-02-14
2024-03-31	$251,601	10,016	-44.7%	Shares	Sole	2024-05-13
2023-09-30	$572,181	18,107	+76.7%	Shares	Sole	2023-11-14
2023-03-31	$246,204	10,250	—	Shares	Other	2023-05-15
No filing history on record for this holder in this stock.